参考文献/References:
[1] Gagala J,Tarczynska M,Gaweda K.Clinical and radiological outcomes of treatment of avascular necrosis of the femoral head using autologous osteochondral transfer(mosaicplasty):preliminary report[J].Int Orthop,2013,37(7):1239-1244.
[2] Signorino JA,Jayaseelan DJ,Brindle K.A typical clinical presentation of rapidly progressing femoral head avascular necrosis[J].J Orthop Sports Phys Ther,2017,47(3):217.
[3] Liu L,Gao F,Sun W,et al.Investigating clinical failure of core decompression with autologous bone marrow mononuclear cells grafting for the treatment of non-traumatic osteonecrosis of the femoral head[J].Int Orthop,2018,42(7):1575-1583.
[4] 李泰贤,陈志伟,王荣田,等.基于文献计量学分析中医药治疗股骨头坏死的研究现状[J].中国中医骨伤科杂志,2017,25(4):41-46.
[5] Zhao L,Kaye AD,Kaye AJ,et al.Stem cell therapy for osteonecrosis of the femoral head:current trends and comprehensive review[J].Curr Pain Headache Rep,2018,22(6):41.
[6] Song HM,Wei YC,Li N,et al.Effects of Wenyangbushen formula on the expression of VEGF,OPG,RANK and RANKL in rabbits with steroid-induced femoral head avascular necrosis[J].Mol Med Rep,2015,12(6):8155-8161.
[7] 徐西林,胡海,张晓峰,等.活骨注射液治疗股骨头坏死的扫描电镜观察[J].中国中医骨伤科杂志,2017,25(2):1-5.
[8] 袁普卫,贺西京,王国毓,等.骨复生胶囊治疗早期儿童股骨头缺血性坏死的临床观察[J].中国中西医结合杂志,2005,25(4):330-332.
[9] 袁普卫,贺西京,周海哲,等.骨复生胶囊对实验性激素性股骨头缺血坏死家兔IGF-1的影响[J].中国中医骨伤科杂志,2007,15(2):40-41.
[10] 袁普卫,刘德玉,贺西京,等.中药复方骨复生对激素性股骨头缺血坏死家兔TNF-α的影响[J].中国骨伤,2004,17(11):662-664.
[11] 贺西京,毛履真,王坤正,等.肾上腺皮质激素引起股骨头缺血性坏死的机制实验研究[J].中华骨科杂志,1992,12(6):440.
[12] 董国华,邱红明.邱红明治疗股骨头坏死经验[J].湖南中医杂志,2017,33(3):34-36.
[13] 邓海军.中医综合疗法治疗股骨头坏死的疗效分析[J].黑龙江中医药,2015,44(6):22-23.
[14] Caplan A,Fett N,Rosenbach M,et al.Prevention and management of glucocorticoid-induced side effects:a comprehensive review:a review of glucocorticoid pharmacology and bone health[J].Journal of the American Academy of Dermatology,2017,76(1):1-9.
[15] Hauzeur JP,Toungouz M,Lechanteur C,et al.Autologous osteoblastic cells(PREOBy)versus concentrated bone marrow implantation in osteonecrosis of the femoral head:a randomized study[J].Revue de Chirurgie Orthopédique et Traumatologique,2016,102(7):S73.
[16] Cui L,Zhuang Q,Lin J,et al.Multicentric epidemiologic study on six thousand three hundred and ninety five cases of femoral head osteonecrosis in China[J].International orthopaedics,2016,40(2):267-276.
[17] Johnson AJ,Mont MA,Tsao AK,et al.Treatment of femoral head osteonecrosis in the United States:16-year analysis of the nationwide inpatient sample[J].Clinical Orthopaedics and Related Research,2014,472(2):617-623.
[18] 康武林,袁普卫.股骨头坏死与骨髓间充质干细胞移植研究进展[J].中国矫形外科杂志,2013,21(19):1954-1957.
[19] 吉万波,刘冠虹,刘锦涛,等.股密葆方对大鼠激素性股骨头坏死血管修复影响的实验研究[J].中国骨质疏松杂志,2014,20(10):1148-1153.
[20] 周李学,李志敏,段璋.活血法防治早期激素性股骨头坏死的研究进展[J].创伤与急诊电子杂志,2015,3(2):1-5.
[21] 陆启恩.股骨头坏死的病因分析及治疗进展[J].实用医技杂志,2014,21(1):44-45.
[22] 罗丹,宋振华,胡建庚,等.补气活血法治疗气虚血瘀型股骨头坏死23例[J].中国中医药现代远程教育,2016,14(2):74-75.
[23] 徐复朕,尹纪光.启功散加减治疗早期股骨头缺血性坏死50例疗效观察[J].湖南中医杂志,2016,32(11):73-74.
[24] 柳锦华,刘建卫.补肾活血汤治疗中老年激素性股骨头坏死的临床效果分析[J].齐齐哈尔医学院学报,2016,37(33):4174-4176.
[25] 章建华,尹华,林婷,等.芪参健骨颗粒对激素性股骨头坏死大鼠骨组织的影响[J].中国中医骨伤科杂志,2014,22(1):1-4..
[26] 陈镇秋,何伟,魏秋实.股骨头坏死中医证型与血液学指标的相关性研究[J].中华中医药杂志,2013,28(7):2205-2208.
[27] 芮丹云,唐丽媛,陈洁,等.补肾活血颗粒对骨质疏松大鼠骨组织中OPG/RANKL mRNA及蛋白表达的影响[J].中国老年学杂志,2015,35(24):7036-7038.
[28] 宋红梅,魏迎辰,吴斌,等.温阳补肾方对兔激素性股骨头坏死组织RANKL/RANK/OPG通路的影响[J].中华中医药杂志,2016,31(1):302-305.